LBG is pleased to announce that Dr. Thijs Beuming, Principal Consultant, In Silico Drug Discovery Services, is participating in a webinar, “Novel Approaches in GPCR Drug Design,” presented by Pharmacelera ™ on June 22 at 10 a.m. EDT.
One of three panelists, Dr. Beuming will speak about the application of free energy calculations to lead optimization in GPCR drug discovery. The free webinar also includes a Q&A session.
Don’t miss this informative, interesting event, which offers attendees an opportunity to learn about new discoveries and challenges pertaining to GPCRs.
For more information, visit https://lnkd.in/dwGiADS.